RE:Tilray Brands - German Cannabis Legalization Update Ben missed some important points on Tilray? Not a very good report, little bit of down play I would say.
Aphria X facility is twice the size of Aurora's. Working at limited capacity due to the 1000kg licence. Demecan as well.
Im sure that capacity will soon be increased by the government, you would think.
https://businessofcannabis.com/german-medical-cannabis-milestone-as-first-homegrown-flowers-distributed-to-patients/
HOMEGROWN medical cannabis is now available to German patients for the first time.
Aphria RX– a wholly-owned subsidiary of Canadian pharmaceutical and cannabis company Tilray – has become the first of the three licensed German producers to achieve this significant milestone.
The medical cannabis crop is the first grown under European Good Manufacturing Practice (EU-GMP) standard in Tilray’s 6,000sq m indoor growing facility in Neumnster, about 40 miles from Hamburg.
Aphria was one of three companies, along with Aurora and Demecan, to be granted a permit by the Federal Institute for Drugs and Medical Devices (BfArM), in spring 2019, to cultivate medicinal cannabis.
HOMEGROWN medical cannabis is now available to German patients for the first time.
Aphria RX– a wholly-owned subsidiary of Canadian pharmaceutical and cannabis company Tilray – has become the first of the three licensed German producers to achieve this significant milestone.
The medical cannabis crop is the first grown under European Good Manufacturing Practice (EU-GMP) standard in Tilray’s 6,000sq m indoor growing facility in Neumnster, about 40 miles from Hamburg.
Aphria was one of three companies, along with Aurora and Demecan, to be granted a permit by the Federal Institute for Drugs and Medical Devices (BfArM), in spring 2019, to cultivate medicinal cannabis.